The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOCl) is suppressed by anti-rheumatic drugs

Free Radical Research

Volumn 28, Issue 2, 1998, Pages 115-123

  Shabani, Fariba ^a   Mcneil, Julian ^a   Tippett, Linda ^a  

^a NONE

Author keywords

Anti rheumatic drugs and hypochlorous acid; Oxidants; Tissue inhibitor of metalloproteinases (TIMP)

Indexed keywords

ANTIRHEUMATIC AGENT; AURANOFIN; AUROTHIOGLUCOSE; AUROTHIOMALATE; CHLOROQUINE; COLLAGENASE; HYPOCHLOROUS ACID; METHOTREXATE; PENICILLAMINE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; DISULFIDE BOND; ENZYME CONFORMATION; ENZYME INACTIVATION;

EID: 0031837825     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.3109/10715769809065797     Document Type: Article

References (34)

1. Bigg, H. F., Clark, I. M. and Cawston, T. E. (1994). Fragments of human fibroblast collagenase: interaction with metalloproteinase inhibitors and substrates. Biochimica et Biophysica Acta, 1208, 157-165.
2. Murphy, G., Docherty, A. J. P., Hembry, R. M. and Reynolds, J. J. (1991). Metalloproteinases and tissue damage. British Journal of Rhumatology, 30 (suppl 1), 25-31.
3. Mallya, S. K., Mookhiar, K. A., Gao, Y., Brew, K., Diozegi, M., Birkedal-Hansen, H. and Van Wart, H. E. (1990). Characterization of 58-Kilodalton human neutrophile collagenase: Comparison with human fibroblast collagenase. Biochemistry, 29, 10628-10634.
4. O'shea, M., Willenbrock, F., Williamson, R. A., Cockett, M. I., Freedman, R. B., Reynolds, J. J., Docherty, A. J. P. and Murphy, G. (1992). Site directed mutations that alter the inhibitory activity of the tissue inhibitor of metalloproteinases: Importance of the N-terminal region between cysteine 3 and cystein 13. Biochemistry, 31, 10146-10152.
5. Williamson, R. A., Bryan, J. S., Angal, S., Murphy, G. and Freedman, R. B. (1993). Structural analysis of tissue inhibitor of metalloproteinases-1 (TIMP-1) by tryptic peptide mapping. Biochimica et Biophysica Acta, 1164, 8-16.
6. Denhardt, D. T., Feng, B., Dylan, R. E., Cocuzzi, E. T. and Malayankar, U. M. (1993). Tissue inhibitor of metalloproteinases (TIMP, aka EPA): Structure, control of expression and biological functions. Pharmacology and Therapeutics, 59, 329-341.
7. Lohmander, L. S., Hoerrner, L. A. and Lark, M. W. (1993). Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis and Rheumatism, 36, 181-9.
8. Birkedal-Hansen, H., Moore, W. G. I., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A. and Engler, J. (1993). Matrix metalloproteinases: A Review. Critical Reviews in Oral Biology and Medicine, 4, 197-250.
9. Weiss, S. J. (1989). Mechanisms of disease: Tissue destruction by neutrophils. The New England Journal of Medicine, 320, 365-376.
10. Laurindo Ieda, M. M., Mello suzana, B. V. and Cossermelli, W. (1995). Influence of low doses of methotrexate on superoxide anion production by polymorphonuclear leukocytes from patients with rheumatoid arthritis. Journal of Rheumatology, 22, 633-8.
11. Weiss, S. J. and Peppin, G. J. (1986). Collagenolytic metalloenzymes of the human neutrophil. Biochemical Pharmacology, 35, 3189-3197.
12. Weiss, S. J., Klein, R., Slivka, A. and Wei, M. (1982). Chlorination of taurine by human neutrophils. Journal of Clinical Investigation, 70, 598-607.
13. Zgliczynski, J. M., Stelmaszynska, T., Domanski, J. and Ostrowski, W. (1971). Chloramine as intermediates of oxidation reaction of amino acids by myeloperoxidase. Biochimica et Biophysica Acta, 235, 419-424.
14. Grisham, M. B., Jefferson, M. M., Melton, D. F. and Thomas, E. L. (1984). Chlorination of endogenous amines by isolated neutrophiles. Journal of Biological Chemistry, 259, 10404-10412.
15. Okada, Y., Watanabe, S., Nakanishi, I., Kishi, J. I., Hayakawa, T., Watorek, W., Travis, J. and Nagase, H. (1988). Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases. FEBS Letters, 229, 157-160.
16. Davies, J. M. S., Horwits, D. A. and Davies, K. J. A. (1993). Potential roles of hypochlorous acid and N-chloroamines in collagen breakdown by phagocytic cells in synovitis. Free Radical Biology & Medicine, 15, 637-643.
17. 1-proteinase inhibitor with neutrophile meyloperoxidase. Biochemistry, 20, 331-336.
18. Frears, E. R., Zhang, Z., Blake, D. R., O'Connell, J. P. and Winyard, P. G. (1996). Inactivation of tissue inhibitor of metalloproteinase-1 by peroxynitrite. FEBS Letters, 381, 21-24.
19. Cuperus, R. A., Muijsers, A. O. and Wever, R. (1985). Antiarthritic drugs containing thiol groups scavenge hypochlorite and inhibit its formation by myeloperoxidase from human leukocytes. Arthritis and Rheumatism, 28, 1228-1233.
20. Pekoe, G., Van, Dyke, K., Mengoli, H., Peden, D. and English, D. (1982). Comparison of the effects of antioxidant non-stroidal anti inflammatory drugs against myeloper-oxidase and hypochlorous acid luminolenhanced chemiluminescence. Agents & Actions, 12, 232-238.
21. Matheson, N. R. (1982). The effect of anti-arthritic drugs and related compounds on the human neutrophil myeloperoxidase system. Biochemical and Biophysical Research Communications, 108, 159-165.
22. Bannwart, B., Labat, L., Monde, Y. and Schaeverbck, T. (1994). Methotrexate in rheumatoid arthritis. Drugs, 47, 25-50.
23. Stevenson, G. A., Lyons, J. G., Cameron, D. A. and O'Grady, R. L. (1985). Rat mammary carcinoma cells in long-term serum free culture provide a continuing supply of collagenase. Bioscience Report, 5, 1071-1077.
24. Netzel-Arnett, S., Mallya, S. K., Nagase, H., Birkedal-Hanson, H. and Van Wart, H. E. (1991). Continusly recording fluorescent assays optimized for five human matrix metalloproteinases. Analytical Biochemistry, 195, 86-92.
25. Test, S. T. and Weiss, S. J. (1986). The generation of utilization of chlorinated oxidants by human neutrophils. Free Radical Biology and Medicine, 2, 91-116.
26. Lark, M. W., Saphos, C. A., Walakovitz, L. A. and Moore, V. L. (1990). In vivo activity of human recombinant tissue inhibitor of metalloproteinases (TIMP). Biochemical Pharmacology, 39, 2041-2049.
27. Pace, C. N., Shirly, B. A. and Thompson, J. A. Protein structure: a practical approach (Creighton, T E., ed.), PP.311-339 IRL Press, Oxford University Press, Oxford.
28. Williamson, R. A., Smith, B. J., Angal, S. and Freedman, R. B. (1993). Chemical modification of tissue inhibitor of metalloproteinases-1 and its inactivation by diethyl pyrocarbonate. Biochimica et Biophysica Acta, 1203, 147-154.
29. Stricklin, J. P. and Hoidal, J. R. (1992). Oxidant-mediated inactivation of TIMP. Matrix Supplement, 1, 325.
30. Muijsers, A. O., van de Stadt, R. J., Henrichs, A. M. A. and van de Korst, J. K. (1979). Determination of D-penicillamine in serum and urine of patients with rheuma-toid arthritis. Clinica Chimica Acta, 94, 173-180.
31. Van de Stadt, R. J., Muijsers, A. O., Henrichs, A. M. A., van de Korst, J. K. (1979). D-penicillamine: biochemical, metabolic, and pharmacological aspects. Scandinavian Journal of Rheumatology (Suppl) 29, 13-20.
32. Hurst, N. P., Georjatschko, L., Betts, W. H., Zalewski, P. D. and Forbes, I. J. (1989). Auranofin modulates human neutrophile superoxide production and protein phosphorylation. Rheumatology International, 8, 245-250.
33. Jellum, E. and Munthe, E. (1982). Fate of the thiomalate part after intramuscular administration of aurothiomalate in rheumatoid arthritis. Annals of Rheumatic Disease, 41, 431-432.
34. Wasil, M., Halliwell, B., Moorehouse, C. P., Hutchison, D. C. and Baum, H. (1987). Biologically-significant scavenging of the myeloperoxidase-derived oxidant hypochlorous acid by some anti-inflammatory drugs. Biochemical Pharmacology, 36(22), 3847-3850.